Scientists have recently discovered a potential new way to screen for effective COVID-19 therapeutics: autophagy-related compounds. Autophagy is a process within cells that is responsible for controlling the destruction of damaged structures and recycling of essential components. Researchers at the University of Tokyo have developed a screening platform that uses autophagy-related compounds to identify potential therapeutics for the virus. This platform could potentially identify compounds that can help to inhibit the replication of the virus, as well as those that can boost the body’s own immune response against it. This could be a major breakthrough in the fight against COVID-19, which has so far been limited by a lack of effective treatments.

Read Full Article Here

source: Phys.org